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Original article
The 8-foot up and go test is the best way to assess
physical function in the rheumatoid arthritis clinic
Thomas J. Wilkinson1,2, Andrew B. Lemmey1, Rebecca J. Clayton1,
Jeremy G. Jones1,3 and Thomas D. O’Brien4
Abstract
Objectives. RA is characterized by poor physical function, which compromises patients’ quality of life
and outcome. Clinical assessment of function is usually performed using self-reported questionnaires,
such as the Multi-Dimensional HAQ (MDHAQ) and the Short Form-36 (physical component) (SF36-PC).
However, such subjective measures may not accurately reflect real functional status. This study aimed
to determine: (i) which clinically practicable objective test best represents overall physical function;
and (ii) the extent to which self-reported subjective functional measures reflect objectively assessed
function.
Methods. Objective [isometric knee extensor strength, handgrip strength, sit-to-stands in 30 s, 8-foot
up and go (80UG), 50-foot walk (500W) and estimated aerobic capacity (V_ O2max)] and subjective
(MDHAQ and SF36-PC) measures of function were correlated with one another to determine the best
overall test of functional status in 82 well-controlled RA patients (DAS28 (S.D.)¼ 2.8 (1.0)).
Results. In rank order of size, averaged correlations (r) to the other outcome measures were as fol-
lows: 80UG: 0.650; 500W: 0.636; isometric knee extensor strength: 0.502; handgrip strength: 0.449; sit-
to-stands in 30 s: 0.432; and estimated V_ O2max: 0.358. The MDHAQ was weakly (0.361) and the
SF36-PC moderately correlated (0.415) with objective measures.
Conclusion. Our results show that the most appropriate measure of objective physical function in RA
patients is the 80UG, followed by the 500W. We found discordance between objectively and subjectively
measured function. In clinical practice, an objective measure that is simple and quick to perform, such
as the 80UG, is advocated for assessing real functional status.
Key words: rheumatoid arthritis, physical function, objective and subjective function tests, 8-foot up and go
test, health assessment questionnaire
Introduction
RA patients typically experience adverse, inflammatory-
driven changes in body composition, which result in
muscle wasting and increased fat mass. This condition,
termed rheumatoid cachexia (RC) [1], is a major contrib-
utor to the impaired physical function of these patients
[2, 3]. Poor physical function is a strong predictor of
clinical outcome in RA, and is associated with increased
morbidity and mortality, reduced quality of life and
Key messages
. The best measure of overall physical function is the 80UG.
. The subjective MDHAQ and SF36-PC questionnaires are both relatively poor measures of objectively assessed
physical function.
. The 80UG and 500W are appropriate tests for assessing functional status of RA patients in routine clinics.
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higher treatment costs [4–6]. Both patients and health-
care professionals identify physical function as a key
outcome in the management of RA [7] and improving
function as an important therapeutic target in clinical care
[6, 8–10]. Hence, accurate assessment of physical func-
tion is required if RA treatment is to be optimized [10].
It was reasoned that improvements in disease man-
agement, specifically early and aggressive tight pharma-
ceutical control of inflammation, such as the current
treat-to-target (T2T) approach [8], would attenuate RC
and the associated poor physical function. However, in
our recent study of 82 T2T RA patients with well-
controlled disease (mean DAS28 of 2.8; 49% in clinical
remission) we found that RC and markedly reduced
physical function are still apparent [11]. Notably, despite
these patients rating their disability as being only mild
on the Multi-Dimensional HAQ (MDHAQ), strength rela-
tive to age- and sex-matched sedentary healthy controls
was reduced by 25%, and performance of objective
physical function tests designed to reflect the ability to
perform activities of daily living (ADL) were reduced by
approximately a third. Worryingly, on average, these
patients with well-controlled disease had the physical
function level typical of healthy sex-matched individuals
25 years older (based on reference values [12]).
Currently, clinical assessment of physical function in
RA patients is performed using subjective, self-reported
questionnaires, such as the HAQ [13] or adaptations of
the HAQ (e.g. the MDHAQ [9, 14, 15]). This has been
justified because of the HAQ’s reliability, adaptability
and ease of use and delivery, and an emphasis on out-
comes that are relevant to the patient (i.e. patient-
reported outcome measures) [16, 17]. Consequently, the
HAQ has become the pre-eminent patient-reported out-
come measure in rheumatology [15] and is recom-
mended for the routine assessment of physical function
by RA management guidelines [9, 14].
However, like most questionnaires, the HAQ suffers
from various psychometric limitations; most notably, as
it was designed to detect impairment among patients
with greater disability than those typically seen today
[17, 18], it consequently suffers from floor effects
(i.e. normal scores despite physical function impair-
ments) [15]. These effects were evident in our recent
trial [11]. It is also well established that these question-
naires are influenced by age, gender, disease duration,
depression, education, social class, ethnicity, person-
ality [10, 18–21] and, especially, pain [22–25]. Notably,
both the HAQ and MDHAQ are insensitive to the large
functional gains (including normalization of objectively
assessed function), which can result from exercise
training [26–28].
Owing to the large number of external influences, it is
unsurprising that self-reported function measures often
show only weak-to-moderate relationships with objective
performance-based tasks in RA patients [11, 19]. This
weak-to-moderate association has also been demon-
strated in the elderly [29, 30] and in lower back pain [31],
OA [32], AS [33] and fibromyalgia patients [34]. Along
with floor effects [15], it has been proposed that the dis-
cordance between the HAQ and objective measures
occurs because subjective measures evaluate what
patients experience when performing activities, rather
than their ability to perform these activities [32]. As such,
objective performance measures contribute information
beyond that obtained from self-reported physical function
[30] and, consequently, objective tests appear to be pref-
erable for assessing real physical function in RA [21].
However, along with the lack of recognition and under-
standing of the relative advantages of objective tests over
subjective questionnaires, the limitations of the clinical
environment (i.e. time, space, equipment, staff and spe-
cific expertise) mitigate against the inclusion of a full bat-
tery of objective function tests in routine clinical RA
management [35]. If objective function testing is to be
adopted and routinely used in clinical practice, there
needs to be clear guidance on which test provides the
best measure of overall physical function.
Thus, the present study aimed to determine: (i) which
clinically practicable objective function test best repre-
sents overall physical function; and (ii) the extent to
which self-reported functional measures reflect
objectively assessed function. The identification of the
best overall objective physical function test in this study
was exploratory and, as such, a hypothesis was not
applicable. However, we did hypothesize that self-
reported functional status [HAQ and SF-36 physical
component (SF36-PC)] would not correlate strongly with
function as indicated by objective tests.
Methods
Study population
Patients with well-controlled, stable RA were recruited
from outpatient clinics of the Peter Maddison
Rheumatology Centre, North Wales. For inclusion, par-
ticipants had to: fulfil the ACR 2010 revised criteria for
RA [36]; be aged 18 years; not be cognitively impaired;
be free of other cachectic diseases or conditions; not
be taking anabolic drugs or nutritional supplements; and
not be pregnant. All patients were diagnosed after 1
January 2008 and had been exclusively treated using
contemporary treatment strategies (T2T). This patient
cohort was recruited for a cross-sectional study that
evaluated the effect of tight control of disease activity
on body composition and physical function in RA
patients [11]. The study was approved by the North
Wales Research Ethics Committee-West (12/WA/0323),
and conducted in compliance with the Declaration of
Helsinki.
Assessments and outcome measures
All outcome measures and protocols have been previ-
ously described in detail [11], so are only briefly
summarized here.
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Physical function
Maximal isometric knee extensor strength (IKES) was
measured using an isokinetic dynamometer (Humac
Cybex Norm 2004; Computer Sports Medicine Inc., MA,
USA), and maximal handgrip strength (HGS) by a Grip-A
dynamometer (Takei Kiki Kogyo, Japan). Objective func-
tion was also assessed by three tests specifically devel-
oped to evaluate the ability of older adults to perform
ADLs [12]: sit-to-stands in 30 s (STS-30), 8-foot up and
go (80UG) and 50-foot walk (500W). Aerobic capacity
(V_ O2max) was estimated using the progressive submaxi-
mal Siconolfi step test [37]. This test has been validated
in RA [38]. Performance of each of these tests was pre-
ceded by a submaximal practice. Our group routinely
uses these tests to assess physical function in RA [11,
27, 28, 38, 39]. In order to promote inclusion into routine
clinical assessments, a full step-by-step guide for deliv-
ery of each of the objective tests described here can be
found in the supplementary data available at
Rheumatology Advances in Practice online.
Subjective physical function was evaluated by the
MDHAQ (scored 0–3, with higher scores denoting poorer
function) as described by Pincus et al. [15]. The MDHAQ
was used because of notable limitations of the HAQ in
well-controlled RA patients; owing to its broader meas-
urement range, this version of the HAQ has been recom-
mended for use in patients with relatively good
functional capacity, such as those in the present study
[15, 17]. We also used the physical component of the
SF36-PC questionnaire (scored 0–100, with lower scores
denoting poorer function) [40]. The SF36-PC is the most
frequently used generic scale of physical function in
patients with RA [17].
Clinical measures
Disease activity was assessed by the DAS28, using
CRP as the marker of systemic inflammation.
Statistical analysis
Pearson’s product–moment correlation coefficient
(Pearson’s r) was used to assess the relationships between
variables of interest. The correlation coefficient was meas-
ured on a scale from 1 through 0 to 1. Complete correla-
tion between two variables is expressed by either 1 or 1,
whereas complete absence of correlation is represented
by 0 [41]. If a variable increases concurrently with another
the correlation is positive, whereas when one variable
decreases as the other increases the correlation is nega-
tive. Correlation strengths were defined according to the
following criteria [41]: weak: r¼ 0.200–0.399; moderate:
r¼0.400–0.599; and strong: r¼0.600–1.00.
In order to quantify the best overall measure of objec-
tive physical function, correlations (r) between each of
the objective tests were averaged for each measure
(e.g. each individual r value between the 80UG and the
rest of the objective tests (i.e. IKES, HGS, STS-30, 500W
and estimated V_ O2max) were averaged to determine a
mean r for 80UG. To reduce skew in the r distribution
[42], r values were first transformed into normally distrib-
uted Fisher z values (z0) using an established formula:
z0 ¼ 0:5In 1þ r
1 r ;
where ln is the natural logarithm function.
Following conversion to z0, these values were averaged
(as above) before the mean z0 value was back-converted
to a final r value (rz0)
0using the inverse formula [42]:
rz0 ¼
exp2z0  r
exp2z0 þ r ;
where exp is the exponential.
Subjective measures of physical function (i.e. MDHAQ
and SF36-PC) were correlated with objective measures
only, using the same rz0 calculation as described above.
To avoid confusion in the Results, the final summed and
transformed correlation for each test (i.e. rz0) is pre-
sented as an r value. Significance was set at P<0.05.
Data were analysed using IBM SPSS Statistics 24, and
are presented as means (S.D.).
Results
Patients
Patient characteristics and mean physical function data
for the 82 RA patients are shown in Table 1. Full patient
demographic data are reported by Lemmey et al. [11].
Correlations between objective and subjective
physical function measures
Table 2 displays the averaged correlations between each
measure of function and the remaining objective function
measures. In rank order of size, they were as follows:
80UG: r¼ 0.650; 500W: r¼ 0.636; IKES: r¼ 0.502; HGS:
r¼ 0.449; STS-30: r¼ 0.432; and V_ O2max: r¼0.358.
Although r values varied between males and females,
80UG and 500W, in that order, were the best measures of
overall function (i.e. highest averaged r values) for both
sexes, as well as for the total patient cohort. For male
patients and for all patients combined, the average corre-
lation for both 80UG and 500W were rated strong.
Averaged correlations (male, female and combined) for
IKES, HGS and STS-30 were all rated as moderate. In
contrast, for both sexes and when all patients were com-
bined, estimated V_ O2max was only weakly associated
with the other function measures.
The MDHAQ was also only weakly correlated with the
objective physical function measures (r¼ 0.361).
Although the SF36-PC performed better, with a
moderate averaged r value of 0.415 (Table 2), its aver-
age r was still lower than for any of the objective tests
(with the exception of the submaximal V_ O2max step
test).
Full individual correlation analysis for the total group,
and for males and females, is shown in Table 3.
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Discussion
Poor physical function is a strong predictor of clinical
outcome in RA [4, 5], and accurate assessment of func-
tion is an essential part of RA management [10]. We
have shown that overall objective physical function, as
determined by a battery of objective function tests, is
best represented by the 80UG test followed by the 500W.
Both these tests, in male and female patients, as well as
for the RA patient cohort overall, showed moderate to
strong correlations with each of the other objective func-
tion tests considered. Additionally, our results show that
the routine, recommended, subjective self-reported
measures (e.g. MDHAQ, SF36-PC) are not representa-
tive of objectively assessed physical function.
Both the 80UG and 500W tests are simple to perform,
require minimal equipment (i.e. markers on the floor
and, in the case of the 80UG, a standardized chair) and
are easy to explain to patients. Each test is scored as
time taken to complete the task (in seconds), and thus,
only additionally requires a stopwatch. Both tests only
take a couple of minutes to explain, and for patients to
practice, and then take <1 min to perform. Unpublished
observations by our group found inter-rater reliability for
the 80UG to be excellent (intraclass correlation coeffi-
cient, ICC¼ 0.972) and for the 500W to be good
(ICC¼0.704). Therefore, provided established protocols
are followed [12] (see supplementary material 1, avail-
able at Rheumatology Advances in Practice online), any
confounding effect of administration and scoring by dif-
ferent health-care professionals is small.
Although the 80UG and 500W were highly correlated
with each other, and both performed well in comparison
with the other objective function tests, we found that the
80UG consistently demonstrated the best correlation.
TABLE 1 Patient characteristics
Characteristic Males (n 5 29) Females (n 5 53) Combined (n 5 82)
Age, years 65.0 (7.8) 58.6 (12.9) 60.9 (11.7)
Disease duration, months 23 (18) 24 (20) 24 (19)
DAS28 2.7 (1.2) 2.9 (0.9) 2.8 (1.0)
Objective physical function
IKES, N 474 (131) 328 (116) 380 (140)
HGS, kg 34.0 (9.6) 21.9 (5.8) 26.5 (8.8)
STS-30 (repetitions) 11.7 (4.2) 12.1 (3.3) 12.0 (3.6)
80UG, s 7.8 (5.6) 7.2 (2.6) 7.4 (3.9)
500W, s 11.0 (7.9) 10.6 (3.1) 10.7 (5.3)
V_ O2max, ml/kg/min 26.0 (7.0) 21.4 (5.2) 22.9 (6.2)
Subjective physical function
MDHAQ (0–3) 0.64 (0.64) 0.53 (0.47) 0.57 (0.54)
SF36-PC (0–100) 42 (11) 43 (10) 43 (10)
Data are presented as means (S.D.). HGS: handgrip strength; IKES: isometric knee extensor strength; MDHAQ: multi-dimen-
sional HAQ; SF36-PC: short-form 36 questionnaire physical component; STS-30, sit-to-stand in 30 s; 80UG: 8-foot up and
go; V_ O2max: estimated aerobic capacity from Siconolfi step test [data from 62 out of 82 RA patients (n¼20 unable to
complete test: male (n¼9), female (n¼11)]; 500W: 50-foot walk.
TABLE 2 Averaged correlations for all objective and subjective physical function measures against the objective function
measures
Variable Males (n 5 29) Females (n 5 53) Combined (n 5 82)
IKES 0.416 (#5) 0.502 (#3) 0.502 (#3)
HGS 0.486 (#3) 0.438 (#5) 0.449 (#4)
STS-30 0.477 (#4) 0.500 (#4) 0.432 (#5)
80UG 0.748 (#1) 0.596 (#1) 0.650 (#1)
500W 0.693 (#2) 0.579 (#2) 0.636 (#2)
V_ O2max 0.335 (#6) 0.310 (#6) 0.358 (#6)
MDHAQ 0.428 0.369 0.361
SF36-PC 0.515 0.412 0.415
Data are presented as correlations between variables (Pearson’s r). Light grey shading indicates moderate correlations
(r¼0.400–0.599), and dark grey shading indicates strong correlations (r¼0.600)–1.00. (#)¼ rank of size for objective
measures. HGS: handgrip strength; IKES: isometric knee extensor strength; MDHAQ: multi-dimensional HAQ; SF36-PC:
short-form 36 questionnaire physical component; STS-30: sit-to-stand in 30 s; 80UG: 8-foot up and go; V_ O2max: estimated
aerobic capacity from Siconolfi step test; 500W: 50-foot walk.
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This is likely to be because the 80UG requires a range of
physical abilities, including lower body strength,
dynamic balance, walking ability, agility and gait speed
[12, 43]. It also replicates an ADL patients would be
required to perform several times a day (e.g. getting up
from a chair to answer the telephone, go to the toilet,
answer the front door, etc.). Although the 500W may be
more appropriate for some patients (e.g. those with diffi-
culties getting out of a chair), its key limitation is the
requirement for an appropriate and safe location to per-
form the test (i.e. a straight corridor of at least 25 feet
(there and back test) free of hospital or clinic traffic). As
such, especially in smaller locations, such as outpatient
clinic rooms, we recommend the 80UG for assessing
objective physical function in RA patients.
In our trial, the Siconolfi step test was used to esti-
mate cardiorespiratory fitness (i.e. V_ O2max). In general,
this measure was poorly correlated with the other tests
of physical function, which aim to reflect the ability of
individuals to perform ADLs. However, as the other
objective tests used were of relatively short duration
(maximum of 30 s continuous physical effort for the
STS-30), they are not as reliant on aerobic capacity to
complete. Nevertheless, although the Siconolfi step test
is not the preferred objective test for assessing disabil-
ity, this test should not be overlooked. It is well estab-
lished that RA patients have low aerobic capacity [44],
and poor V_ O2max is associated with an adverse cardio-
vascular profile (e.g. blood pressure, insulin resistance,
high-density lipoprotein) and increased 10-year cardio-
vascular disease risk in RA [45]. Consequently, the sub-
maximal Siconolfi step test, a valid and reproducible
measure of V_ O2max in RA [38], is a useful means of
evaluating a key cardiovascular disease risk factor,
namely aerobic capacity, in RA patients.
We found a discordance between subjective and
objective measures of physical function. In particular,
the MDHAQ was only weakly associated with objective
measures. The HAQ is the recommended measure of
physical function in current RA management [9, 13–16].
TABLE 3 Correlates between physical function measures (objective and subjective) in all RA patients, male RA patients
and female RA patients
Objective physical function Subjective physical function
IKES HGS STS-30 80UG 500W V_ O2max MDHAQ SF36-PC
All RA patients
IKES 0.680** 0.378* 20.456** 20.490** 0.466** 20.166 0.344*
HGS 0.680** 0.228* 20.388** 20.363* 0.515** 20.258* 0.237*
STS-30 0.378* 0.228* 20.641** 20.553** 0.289* 20.262* 0.410*
80UG 20.456** 20.388** 20.641** 0.958** 20.285* 0.546** 20.536**
500W 20.490** 20.363* 20.553** 0.958** 20.203 0.522** 20.515**
V_ O2max 0.466** 0.515** 0.289* 20.285* 20.203 20.171 0.137
MDHAQ 20.166 20.258* 20.262* 0.546** 0.522** 20.171 20.627**
SF36-PC 0.344* 0.237* 0.410* 20.536** 20.515** 0.137 20.627**
Male RA patients
IKES 0.522* 0.370 20.422* 20.405* 0.354 20.089 0.429*
HGS 0.522* 0.252 20.646** 20.578* 0.371 20.522* 0.499*
STS-30 0.370 0.252 20.707** 20.607* 0.348 20.169 0.392*
80UG 20.422* 20.646** 20.707** 0.980** 20.415 0.644** 20.622**
500W 20.405* 20.578* 20.607* 0.980** 20.173 0.593* 20.590**
V_ O2max 0.354 0.371 0.348 20.415 20.173 20.283 0.118
MDHAQ 20.089 20.522* 20.169 0.644** 0.593* 20.283 20.682**
SF36-PC 0.429* 0.499* 0.392* 20.622** 20.590** 0.118 20.682**
Female RA patients
IKES 0.556** 0.517** 20.515** 20.534** 0.376* 20.340* 0.374*
HGS 0.556** 0.447** 20.380** 20.350* 0.445** 20.285* 0.195
STS-30 0.517** 0.447** 20.620** 20.565** 0.316* 20.331* 0.427*
80UG 20.515** 20.380** 20.620** 0.909** 20.217 0.422* 20.504**
500W 20.534** 20.350* 20.565** 0.909** 20.179 0.459* 20.528**
V_ O2max 0.376* 0.445** 0.316* 20.217 20.179 20.162 0.201
MDHAQ 20.340* 20.285* 20.331* 0.422* 0.459* 20.162 20.593**
SF36-PC 0.374* 0.195 0.427* 20.504** 20.528** 0.201 20.593**
Data are presented as correlations between variables (Pearson’s r). Light grey shading indicates moderate correlations
(r¼0.400–0.599), and dark grey shading indicates strong correlations (r¼0.600–1.00). *P<0.05. **P < 0.001. Significant
correlations are in bold. HGS: handgrip strength; IKES: isometric knee extensor strength; MDHAQ: multi-dimensional HAQ;
SF36-PC: short-form 36 questionnaire physical component; STS-30: sit-to-stand in 30 s test; 80UG : 8-foot up and go;
V_ O2max: estimated aerobic capacity from Siconolfi step; 50
0W: 50-foot walk.
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However, the self-reported nature of the HAQ means
that it is influenced by many external factors, such as
age and sex [10, 18–21] and, especially, pain [22–25].
Furthermore, the HAQ was originally intended to detect
much larger functional deficits than those typically seen
in the well-controlled patients of today [18] and, as
such, floor effects (i.e. normal scores despite limited
function) are observed [15, 17, 18, 21]. The development
of the MDHAQ was claimed to reduce these floor effects
by 13% compared with the original HAQ [15], making it
more suitable for patients with well-controlled disease
and relatively better physical function [17]. However,
previous findings by our group (i.e. mild physical func-
tion score on the MDHAQ, but substantial objective
functional deficits in well-treated current patients) indi-
cate that floor effects persist in the MDHAQ [11].
Previous research into the relationship between sub-
jective and objective measures in RA has shown large
discordance between the HAQ and the observed ability
of patients to perform tasks in the HAQ (e.g. tying shoe-
laces, doing up buttons) [19]. Objective function tests
also correlate better with joint damage. Arvidson et al.
[21] found that grip strength, walking capability and the
ability to get out of a chair were strongly associated
with radiographic joint damage (assessed by the modi-
fied Larsen score), whereas no correlation was found
between Larsen and HAQ scores. Not surprisingly, these
authors concluded that objective functional tests are
preferable to HAQ for assessing physical function in RA
patients.
Additionally, in the assessment of physical function, it
is also important that the measure used is sufficiently
sensitive to detect changes after treatment or interven-
tion. Although self-reported physical function (e.g. the
HAQ) generally shows improvement when a patient
responds to pharmaceutical treatment (especially when
the patient initially has uncontrolled disease activity), this
response is strongly influenced by the reduction in pain
that usually accompanies reduced inflammation [25] and
may not necessarily reflect improvement in physical func-
tion capacity. Conversely, it is known that in patients with
controlled RA, the HAQ and MDHAQ are insensitive to
the large objective functional gains (including
normalization of function) that result from high-intensity
exercise training [26–28]. Consequently, it is important
that objective, rather than subjective self-reported, meas-
ures are used to assess intervention-derived functional
improvements in patients with stable RA.
As stated, the HAQ and MDHAQ have notable defi-
ciencies, including floor effects [11, 15], considerable
confounding factors [10, 18, 23, 24] and an inability to
detect functional impairment in well-controlled patients
[17, 18] or identify changes after exercise training [26,
28]. Nevertheless, the HAQ is recommended by interna-
tional guidelines [9, 14] and the literature [16] and
remains the cornerstone of functional assessment in
routine RA management because of its high internal
consistency, test–retest reliability, responsiveness to
change in disease activity [17] and, from the clinician’s
perspective, limited need for training and quick ease of
delivery and evaluation [15, 16]. Despite the shortcom-
ings of subjective measures, the patient perception of
physical function is an important component of medical
care, as greater perceived difficulty in performing func-
tional tasks is associated with poorer global and psy-
chological status, dissatisfaction, reduced quality of life,
loss of independence and mortality [15, 16, 30].
In comparison to the MDHAQ, we found that the
SF36-PC was a marginally better indicator of overall
objective physical functioning. In addition, the full SF36
has the ability to measure mental health (not measured
here) and may be more relevant in assessing the eco-
nomic impacts (i.e. via quality-adjusted life-years) of
treatment [46], which may be particularly pertinent to
RA, where expensive biologic treatment is frequently
used. Nonetheless, although the SF36-PC may be a
more accurate depiction of physical function than the
HAQ in RA, it is unlikely to be widely adopted into rou-
tine rheumatology practice for the following reasons: (i)
it is a generic instrument, whereas the HAQ and its
derivatives are RA specific [17]; (ii) there are expensive
annual licence fees for software and the questionnaire
itself [47]; and (iii) relative to the HAQ, evaluating the
SF36-PC is arduous and requires specialized scoring
software.
The lack of agreement between objectively and subjec-
tively assessed function reported in RA [19, 21], the elderly
[29, 30] and other rheumatic conditions, including back
pain, OA, AS and FM [33], may arise from inaccurate
reporting, limited response criteria and/or measurement
error or, alternatively, because performance-based meas-
ures may not assess all aspects that influence a partici-
pant’s subjective functional assessment of that task [30].
Accordingly, because objective and subjective measures
provide information on different aspects of physical func-
tion [21, 32], they may be complementary and, in combina-
tion, should provide a more comprehensive understanding
of a person’s functional status [30]. However, owing to the
numerous deficiencies of subjective measures, an objec-
tive measure should routinely be assessed.
A limitation of the present study is the largely homo-
geneous cohort assessed. Patients were generally well
controlled [mean DAS28-CRP (S.D.)¼2.8 (1.0), 49% in
remission] and, in this regard, our finding that the 80UG
is the most appropriate function test may only be appli-
cable to patients with stable and generally low disease
activity. Although the 80UG remains a potentially feasible
and practical test for patients with high disease activity
to perform, additional research should confirm whether
this test is also the best overall measure of physical
function in this group of patients. Future research could
also investigate relevant cut-off points for objective
physical function performance in RA patients. Previous
work in the elderly [30, 48] and other clinical popula-
tions, such as Parkinson’s disease [43] and diabetic
peripheral neuropathy [49], has shown that 80UG cut-
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offs can accurately predict functional mobility skills (e.g.
getting into a shower) and fall risk.
Conclusion
Our results show that the 80UG, followed by the 500W,
demonstrate the strongest correlations with other meas-
ures of physical function. Consequently, the 80UG
appears to be the most appropriate objective assessment
to assess overall physical function of patients with RA.
We found a discordance between function measured by
objective tests and that measured subjectively by the
MDHAQ and SF36-PC questionnaires. Consequently, in
clinical practice, the addition of an objective measure,
such as the 80UG, which is simple and quick to perform,
is advocated for determining a patient’s real physical
function, and may provide a more accurate and compre-
hensive picture of a patient’s functional status.
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